Standard nerve conduction studies often overlook small fiber neuropathy. Learn how advanced sudomotor testing provides the clarity needed for earlier diagnosis and better patient outcomes.
Published November 5, 2026
In clinical neurology, a recurring diagnostic challenge involves patients presenting with burning pain, paresthesia, and sensory disturbances who nonetheless show normal findings on traditional nerve conduction studies (NCS). This disconnect occurs because NCS only assess large-diameter, myelinated nerve fibers. Small fiber neuropathy (SFN), which involves the damage to A-delta and C-fibers, remains invisible to standard electrodiagnostic equipment. For these patients, autonomic nerve damage is often the earliest harbinger of systemic disease, yet it frequently goes undiagnosed until clinical symptoms are severe.
Small fiber neuropathy is characterized by the degeneration of unmyelinated nerve fibers, which include the sudomotor fibers that regulate sweat gland function. Because the sweat glands are exclusively innervated by sympathetic cholinergic fibers, measuring the secretory response of these glands serves as a reliable surrogate marker for the integrity of these small, autonomic nerves.
Unlike traditional NCS, sudomotor testing provides a objective, quantitative measure of autonomic function. When patients report systemic neuropathic symptoms without large-fiber deficits, integrating sudomotor function assessment—specifically using technology like the SudoCheck within the VitalScan ANS+ system—allows clinicians to detect autonomic dysfunction in its nascent stages. This objective data serves to bridge the gap between patient reporting and clinical verification, often providing the first tangible evidence of SFN.
Effective diagnostics require a balance of clinical precision and practice workflow efficiency. The VitalScan ANS+ system, manufactured by US MedResources, offers a non-invasive, 15-minute diagnostic suite that can be administered by existing clinical staff.
By incorporating the VitalScan ANS+ into your practice, you gain a comprehensive physiological profile, including:
This platform produces an automated, physician-ready report, allowing for real-time decision-making before the patient exits the office. This immediacy is critical for maintaining patient engagement and facilitating early therapeutic intervention.
Clinical guidelines from bodies such as the American Diabetes Association (ADA) and the American Heart Association (AHA) increasingly emphasize the importance of identifying autonomic dysfunction as a marker for systemic disease. Early detection of nerve damage allows for tighter glycemic control in diabetic patients and earlier cardiac risk stratification.
Practically, the integration of these diagnostics is supported by clear coding pathways. Physicians can utilize CPT codes 95921-95924 for autonomic nervous system testing, alongside 93922-93971 for comprehensive vascular studies. This reimbursement framework ensures that the commitment to improved diagnostic rigor also aligns with the fiscal health of the neurological practice.
Why does early detection matter? Autonomic nerve damage is rarely an isolated event; it is often a window into a patient’s broader systemic metabolic or autoimmune status. Detecting SFN early permits a shift from palliative symptom management to disease-modifying treatment. By the time a patient presents with clear sensory loss or gait instability, the damage is often irreversible. By identifying subclinical sudomotor dysfunction today, clinicians can implement targeted interventions to arrest or slow the progression of neurological decline.
Standard nerve conduction studies are insufficient for detecting early-stage small fiber neuropathy. The incorporation of advanced sudomotor testing via the VitalScan ANS+ system provides an efficient, evidence-based method to quantify autonomic nerve damage, support diagnosis through CPT-reimbursable testing, and significantly improve long-term outcomes for patients with neuropathic pain.
One-Page Reference
Code descriptions, typical reimbursement ranges, ICD-10 pairings, and the CMS bundling note to check before you bill.
Enter your typical daily volume and reimbursement to see monthly revenue, payback period, and a downloadable ROI report.